Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
Vertex specializes in corporate tax compliance software, targeting a $22B global TAM with a focus on enterprise and SMB ...
The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
India Today on MSN1d
Vertex: New non-opioid painkiller Journavx approved by FDAThe FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback